Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Mediaco Holding Inc. - Class A | 3WX | Sep 27, 2024 | 1.12 | -2.61 |
MEDIAN POLSKA S.A. ZY-,10 | GY3 | Sep 27, 2024 | 0.15 | -0.65 |
Median Technologies | 4ZG | Sep 27, 2024 | 4.20 | +3.45 |
Mediaseek Inc. | 6WJ | Sep 27, 2024 | 1.81 | +1.12 |
Medibank Private Limited | MPV | Sep 27, 2024 | 2.20 | +0.92 |
Medical Facilities Corp | 31F | Sep 27, 2024 | 9.00 | -1.10 |
Medical Properties Trust Inc | M3P | Sep 27, 2024 | 5.22 | +0.64 |
Mediclin AG | MED | Sep 27, 2024 | 2.26 | +0.89 |
Medicover B | 5M0B | Sep 27, 2024 | 17.02 | +1.79 |
Medicure Inc | NGQ1 | Sep 27, 2024 | 0.61 | -0.81 |
MEDICUS PHARMA LTD. | N46 | Sep 27, 2024 | 0.57 | 0.00 |
MEDIFAST INC | MDF | Sep 27, 2024 | 16.70 | +1.15 |
Medigene AG | MDG1 | Sep 27, 2024 | 2.06 | -1.67 |
Medimi | 79T | Sep 27, 2024 | 0.00 | +200.00 |
Medincell S.A. | MEB | Sep 27, 2024 | 15.78 | -0.75 |
MEDIOBANCA S.P.A.UNSP.ADR | ME90 | Sep 27, 2024 | 15.20 | +2.01 |
Mediobanca SpA | ME9 | Sep 27, 2024 | 15.36 | +0.69 |
Medion AG | MDN | Sep 27, 2024 | 14.70 | -0.68 |
Medios AG | ILM1 | Sep 27, 2024 | 15.90 | +0.63 |
Medipal Holdings Corporation | 59Z | Sep 27, 2024 | 15.60 | -0.64 |
Medipharm Labs Corp | MLZ | Sep 27, 2024 | 0.04 | -7.44 |
Medistim | MD1 | Sep 27, 2024 | 14.80 | -1.00 |
MEDIVIR AB | MVR0 | Sep 27, 2024 | 0.24 | +2.11 |
MediWound Ltd. - Ordinary Shares | M8W | Sep 27, 2024 | 14.70 | -2.00 |
Medley Inc. | 3YV | Sep 27, 2024 | 23.20 | +5.45 |
Medmira Inc | 47M | Sep 27, 2024 | 0.05 | -1.03 |
Mednax, Inc. | PDC | Sep 27, 2024 | 10.00 | +3.09 |
Medpace Holdings, Inc. | 01P | Sep 27, 2024 | 296.40 | +1.65 |
MedPeer Inc | 9UN | Sep 27, 2024 | 3.52 | -1.68 |
Medtronic plc. Ordinary Shares | 2M6 | Sep 27, 2024 | 80.55 | +0.83 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.